文献速递腹部泌尿生殖MR

个体化医疗时代MRI在直肠癌中不断演变的作用

MRI's evolving role in rectal cancer in the era of personalized medicine.
PubMed 文献 · Abdom Radiol (NY) · 2025-06-30

综述概述MRI在直肠癌诊疗中的核心作用:用于局部 staging 与风险分层、再分期及监测,并讨论其支持全程新辅助治疗、器官保留等新策略的价值。文章强调MRI在评估早期肿瘤、淋巴结受累、壁外血管侵犯及治疗反应方面仍存在局限,并探讨先进MRI序列、人工智能与影像组学的潜在角色。

要点

  • MRI是直肠癌局部 staging、风险分层、再分期和监测的关键工具。
  • MRI可评估局部肿瘤浸润深度、直肠系膜筋膜受累、淋巴结转移及神经和淋巴管侵犯。
  • MRI在识别早期肿瘤、淋巴结受累、壁外血管侵犯及治疗反应方面仍存在局限。

核心结论

  • MRI在个体化直肠癌治疗决策中起关键作用,但评估变异性和对关键临床特征的识别局限尚未克服。

研究设计与样本

  • 综述,检索范围与纳入文献原文未报告。

临床应用与阅片要点

  • MRI用于直肠癌局部 staging 与风险分层、再分期及监测,以指导个体化治疗。
  • 影像可评估局部肿瘤播散特征(浸润深度、直肠系膜筋膜受累、淋巴结转移、神经和淋巴管侵犯)的预后与决策意义。
  • 影像可评估全身播散风险特征(壁外血管侵犯和肿瘤沉积)的预后与决策意义。
  • MRI支持全程新辅助治疗、器官保留等新治疗策略。
  • 先进MRI序列、人工智能和影像组学在临床决策中的潜在角色尚待探索。

局限性

  • 评估的变异性尚未克服。
  • 识别关键临床特征(如早期肿瘤、淋巴结受累、壁外血管侵犯和治疗反应)的局限性尚未克服。
  • 评估直肠癌某些关键组织学、分子和遗传特征以及治疗反应方面存在局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Recent decades have seen great advances in the diagnosis and management of rectal cancer, and magnetic resonance imaging (MRI) has become pivotal for decision making. New treatments include total neoadjuvant therapy for locally advanced disease, with neoadjuvant immunotherapy, radiotherapy, or chemotherapy alone offering viable alternatives to conventional chemoradiotherapy. Minimally invasive surgical and endoscopic techniques and organ preservation strategies after neoadjuvant therapy have expanded personalized therapeutic options. In this scenario, where it is crucial to tailor treatment to individual patients, MRI plays a critical role in guiding management, including local staging and risk stratification, restaging, and surveillance. However, variability in assessments and limitations in identifying key clinical features (e.g., early-stage tumors, lymph-node involvement, extramural vascular invasion, and responses to treatment) are challenges that have not yet been overcome. This review provides an overview of the current role of MRI in rectal cancer, emphasizing how imaging can refine tailored treatment strategies to improve patient outcomes. It highlights the prognostic and decision-making implications of MRI-based features of local tumor spread (depth of invasion, mesorectal fascia involvement, lymph-node metastases, and perineural and lymphatic invasion) and risk of systemic dissemination (extramural vascular invasion and tumor deposits). It discusses MRI's role in supporting new therapeutic strategies (total neoadjuvant therapy, organ preservation, etc.), evaluating its limitations in assessing some key histological, molecular, and genetic features of rectal cancer as well as in assessing the response to treatment. Finally, it ponders the potential roles of advanced MRI sequences, artificial intelligence, and radiomics in clinical decision making.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. García-Figueiras R, Baleato-Gonzalez S, Kim DH, et al. MRI's evolving role in rectal cancer in the era of personalized medicine. Abdom Radiol (NY). 2025. PMID: 40586896. doi:10.1007/s00261-025-05064-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。